A webinar hosted by the International Education Subcommittee of the Education Committee and the International Academy of Toxicologic Pathology (IATP) Webinar Committee to be held on Friday, May 15, 2026.
This webinar will provide a comprehensive overview of the evolving nonclinical safety assessment frameworks for Antibody–Drug Conjugates (ADCs) and T Cell Engagers (TCEs) in both oncology and non-oncology settings. As these novel therapeutic modalities continue to expand across indications, understanding their unique safety considerations has become increasingly important for toxicologic pathologists and toxicologists worldwide. The session will feature three expert speakers who will cover key areas, including the basic biology and mechanisms of TCEs, current approaches to nonclinical safety assessment for ADCs and TCEs, and regulatory considerations, particularly in the context of autoimmune diseases. This timely and highly relevant webinar is designed to benefit professionals in the United States and internationally by providing practical insights and fostering a deeper understanding of these complex and rapidly advancing therapeutic platforms.